5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) overcomes pharmacological insulin suppression of net hepatic glucose output (NHGO)

被引：0
|
作者：
Camacho, RC
Lacy, DB
James, F
Wasserman, DH
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A372 / A372
页数：1
相关论文
共 50 条
  • [1] Portal venous 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output
    Camacho, RC
    Pencek, RR
    Lacy, DB
    James, FD
    Donahue, EP
    Wasserman, DH
    DIABETES, 2005, 54 (02) : 373 - 382
  • [2] 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin
    Camacho, RC
    Lacy, DB
    James, FD
    Donahue, EP
    Wasserman, DH
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (06): : E1039 - E1043
  • [3] Identification of Yeast and Human 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAr) Transporters
    Ceschin, Johanna
    Saint-Marc, Christelle
    Laporte, Jean
    Labriet, Adrien
    Philippe, Chloe
    Moenner, Michel
    Daignan-Fornier, Bertrand
    Pinson, Benoit
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (24) : 16844 - 16854
  • [4] 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo
    Hasenour, Clinton M.
    Ridley, D. Emerson
    Hughey, Curtis C.
    James, Freyja D.
    Donahue, E. Patrick
    Shearer, Jane
    Viollet, Benoit
    Foretz, Marc
    Wasserman, David H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) : 5950 - 5959
  • [5] 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside causes acute hepatic insulin resistance in vivo
    Pencek, RR
    Shearer, J
    Camacho, RC
    James, FD
    Lacy, DB
    Fueger, PT
    Donahue, EP
    Snead, W
    Wasserman, DH
    DIABETES, 2005, 54 (02) : 355 - 360
  • [6] Disruption of Nucleotide Homeostasis by the Antiproliferative Drug 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside Monophosphate (AICAR)
    Ceschin, Johanna
    Huerlimann, Hans Caspar
    Saint-Marc, Christelle
    Albrecht, Delphine
    Violo, Typhaine
    Moenner, Michel
    Daignan-Fornier, Bertrand
    Pinson, Benoit
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (39) : 23947 - 23959
  • [7] 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) improves lipid utilization but not survival following prolonged hemorrhagic shock
    Calderon, Alfredo
    Kennard, Cianna
    Klemke, Harold
    Marshall, Stephanie
    Meledeo, Michael
    Xiang, Lusha
    PHYSIOLOGY, 2024, 39
  • [8] Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside
    Eloise A Bradley
    Lei Zhang
    Amanda J Genders
    Stephen M Richards
    Stephen Rattigan
    Michelle A Keske
    Cardiovascular Diabetology, 14
  • [9] Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
    Bradley, Eloise A.
    Zhang, Lei
    Genders, Amanda J.
    Richards, Stephen M.
    Rattigan, Stephen
    Keske, Michelle A.
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [10] The Role of Nitric Oxide in the Antidepressant Actions of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in Insulin-Resistant Mice
    Liu, Weina
    Wang, Yangkai
    Li, Haipeng
    Ji, Liu
    PSYCHOSOMATIC MEDICINE, 2016, 78 (01): : 102 - 112
12345